Literature DB >> 19488934

Increased visfatin and leptin in pregnancies complicated by pre-eclampsia.

Ertan Adali1, Recep Yildizhan, Ali Kolusari, Mertihan Kurdoglu, Guler Bugdayci, Hanim Guler Sahin, Mansur Kamaci.   

Abstract

OBJECTIVE: To evaluate the role of the adipokines, visfatin and leptin in the pathophysiology of pre-eclampsia and how their concentrations correlate with the severity of the disease and abnormal Doppler velocimetry.
METHODS: A cross-sectional study was carried out in 72 pregnant women (30 patients with mild pre-eclampsia, 20 patients with severe pre-eclampsia and 22 healthy normotensive pregnant women) during the third trimester of pregnancy. The maternal levels of plasma visfatin and serum leptin were determined in all cases by enzyme immunoassay and enzyme-linked immunosorbent assay, respectively. The uterine artery and umbilical artery RI were determined by Doppler analysis in all cases.
RESULTS: Plasma visfatin levels and serum leptin levels were higher in patients with pre-eclampsia than in the normotensive pregnant women. Six patients with mild pre-eclampsia and five patients with severe pre-eclampsia had abnormal Doppler velocimetry. Visfatin and leptin levels of pre-eclamptic patients with abnormal Doppler velocimetry were significantly higher than they were in those with normal Doppler velocimetry. Serum leptin levels were positively correlated with plasma visfatin level in cases of pre-eclampsia.
CONCLUSIONS: These findings suggest that increased maternal levels of leptin and visfatin may be involved in the pathogenesis of pre-eclampsia, and measurement of these adipokines may be useful in assessment of the severity of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488934     DOI: 10.1080/14767050902994622

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  15 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

2.  Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.

Authors:  M R Luizon; A C T Palei; V A Belo; L M Amaral; R Lacchini; G Duarte; R C Cavalli; V C Sandrim; J E Tanus-Santos
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

3.  Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Sun Kwon Kim; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-05       Impact factor: 1.901

4.  Mid-pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery.

Authors:  Monal R Shroff; Claudia Holzman; Yan Tian; Rhobert W Evans; Alla Sikorskii
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

5.  Protective proteins and telomere length in placentas from patients with pre-eclampsia in the last trimester of gestation.

Authors:  Autumn J Broady; Matthew H Loichinger; Hyeong Jun Ahn; Philip M C Davy; Richard C Allsopp; Gillian D Bryant-Greenwood
Journal:  Placenta       Date:  2016-12-18       Impact factor: 3.481

6.  Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.

Authors:  Marcelo R Luizon; Vanessa A Belo; Ana Ct Palei; Lorena M Amaral; Riccardo Lacchini; Valeria C Sandrim; Geraldo Duarte; Ricardo C Cavalli; Jose E Tanus-Santos
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

7.  Chronic hyperleptinemia results in the development of hypertension in pregnant rats.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

8.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

9.  Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Bo H Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-01-19       Impact factor: 3.886

10.  Different profile of serum leptin between early onset and late onset preeclampsia.

Authors:  Saeedeh Salimi; Farzaneh Farajian-Mashhadi; Anoosh Naghavi; Mojgan Mokhtari; Mahnaz Shahrakipour; Mohsen Saravani; Minoo Yaghmaei
Journal:  Dis Markers       Date:  2014-01-23       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.